Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Public offering

SK Bioscience goes directly to’Tasang’…  740 million money cushion per employee

SK Bioscience goes directly to’Tasang’… 740 million money cushion per employee

Genoco-Giant Staff demand forecasting to come along with the box office… Does the public offering craze continue?

Genoco-Giant Staff demand forecasting to come along with the box office… Does the public offering craze continue?

SK Bioscience Public Offering Stock Subscribers Conflict’Happiness’ in Choosing a Securities Company

SK Bioscience Public Offering Stock Subscribers Conflict’Happiness’ in Choosing a Securities Company

‘Big 3′, leading the success of SK Bioscience,’Attention’ of global IB capabilities

‘Big 3′, leading the success of SK Bioscience,’Attention’ of global IB capabilities

‘IPO Daewoo’ SK Bioscience subscription for two days…  Shall we go’Dad

‘IPO Daewoo’ SK Bioscience subscription for two days… Shall we go’Dad

Coinbase listing report analysis: Defi Satoshi Nakamoto risk

Coinbase listing report analysis: Defi Satoshi Nakamoto risk

Coinbase listing report analysis: Defi Satoshi Nakamoto risk

Coinbase listing report analysis: Defi Satoshi Nakamoto risk

Started IPO of domestic pharmaceutical bio company…  Waiting for HK inno.N etc.

Started IPO of domestic pharmaceutical bio company… Waiting for HK inno.N etc.

SoluM, 1,168 to 1 in demand forecasting competition

SoluM, 1,168 to 1 in demand forecasting competition

[탐사기획] ② Shinpoong Pharmaceutical “No comment on ownership of Piramax…  Checking the Phase 3 report”

[탐사기획] ② Shinpoong Pharmaceutical “No comment on ownership of Piramax… Checking the Phase 3 report”

[탐사기획] ② Shinpoong Pharmaceutical “No comment on ownership of Piramax…  Checking the Phase 3 report”

[탐사기획] ② Shinpoong Pharmaceutical “No comment on ownership of Piramax… Checking the Phase 3 report”

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en